Clinical Trials

Explore eczema clinical trials across Australia and help shape the future of treatment.

Clinical trials play a vital role in improving eczema treatments and deepening our understanding of the condition. On this page, you'll find information about eczema-related clinical trials happening across Australia, including how to participate, what to expect, and who might be eligible. Whether you're considering taking part or simply want to stay informed, we're here to guide you every step of the way and help you make confident, informed decisions about your eczema care.

Momentum Inline Logo_Pine

Huia Eczema Study 

Momentum Clinical Research NZ

  • Momentum Clinical Research is looking for adults aged 18–65 with moderate to severe atopic dermatitis (eczema) to take part in a clinical trial of an investigational medication for the treatment of eczema. Eligible participants will receive three IV infusions every 2 weeks (Weeks 0, 2, and 4) and then attend clinic visits for health check-ups through to Week 52.
  • Requirements
    • Age: 18–65 years
    • Eczema diagnosis: At least 1 year, with moderate–severe severity (covering about 10 palm-sized handprints over the body)
      • BMI: At least 18.5 and less than 40.0 kg/m²
    • Willing to use highly effective contraceptives through 336 days after last dose
  • Reimbursement: Eligible participants will be reimbursed up to $560 for the screening visit, each dosing visit and $375 for all other visits. 
EAA Ongoing Support

Get the ongoing support you need and deserve

Don't let eczema hold you back - invest in your well-being and embrace a brighter tomorrow with our yearly membership.